
Moelis & Company (NYSE:MC – Free Report) – Equities researchers at Zacks Research raised their FY2025 EPS estimates for shares of Moelis & Company in a research note issued to investors on Tuesday, January 6th. Zacks Research analyst Team now forecasts that the asset manager will earn $2.56 per share for the year, up from their previous forecast of $2.54. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Moelis & Company’s current full-year earnings is $2.97 per share. Zacks Research also issued estimates for Moelis & Company’s Q4 2025 earnings at $0.71 EPS, Q2 2026 earnings at $0.66 EPS, Q4 2026 earnings at $0.88 EPS, FY2026 earnings at $2.93 EPS, Q1 2027 earnings at $1.02 EPS, Q2 2027 earnings at $1.05 EPS and FY2027 earnings at $4.38 EPS.
A number of other brokerages have also recently commented on MC. BMO Capital Markets initiated coverage on Moelis & Company in a report on Friday, October 3rd. They issued a “market perform” rating and a $74.00 target price on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Moelis & Company in a research report on Monday, December 29th. Morgan Stanley raised their price objective on Moelis & Company from $86.00 to $89.00 and gave the stock an “overweight” rating in a research note on Tuesday. Keefe, Bruyette & Woods downgraded Moelis & Company from an “outperform” rating to a “market perform” rating and boosted their price objective for the company from $78.00 to $80.00 in a research note on Tuesday, December 16th. Finally, UBS Group raised their target price on shares of Moelis & Company from $70.00 to $74.00 and gave the stock a “neutral” rating in a research note on Wednesday. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Moelis & Company currently has a consensus rating of “Hold” and an average price target of $72.00.
Moelis & Company Price Performance
Shares of Moelis & Company stock opened at $74.58 on Thursday. Moelis & Company has a 1-year low of $47.00 and a 1-year high of $82.89. The company’s fifty day simple moving average is $66.86 and its 200-day simple moving average is $68.88. The stock has a market capitalization of $5.84 billion, a PE ratio of 24.94, a P/E/G ratio of 0.62 and a beta of 1.85.
Moelis & Company (NYSE:MC – Get Free Report) last announced its earnings results on Wednesday, October 29th. The asset manager reported $0.68 EPS for the quarter, beating analysts’ consensus estimates of $0.57 by $0.11. Moelis & Company had a net margin of 15.98% and a return on equity of 45.62%. The business had revenue of $356.89 million during the quarter, compared to analysts’ expectations of $336.14 million. During the same period in the prior year, the company earned $0.22 earnings per share. The firm’s revenue was up 30.4% on a year-over-year basis.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. New England Research & Management Inc. raised its position in shares of Moelis & Company by 10.6% during the fourth quarter. New England Research & Management Inc. now owns 6,000 shares of the asset manager’s stock valued at $412,000 after buying an additional 575 shares during the last quarter. Tudor Investment Corp ET AL purchased a new position in Moelis & Company during the third quarter valued at $5,718,000. Allworth Financial LP grew its stake in Moelis & Company by 153.9% during the third quarter. Allworth Financial LP now owns 419 shares of the asset manager’s stock valued at $30,000 after acquiring an additional 254 shares in the last quarter. Swiss Life Asset Management Ltd bought a new stake in Moelis & Company in the 3rd quarter valued at $244,000. Finally, JPMorgan Chase & Co. lifted its stake in Moelis & Company by 1.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 962,778 shares of the asset manager’s stock worth $68,665,000 after purchasing an additional 17,220 shares in the last quarter. 91.53% of the stock is currently owned by institutional investors.
Moelis & Company Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Thursday, December 4th. Investors of record on Monday, November 10th were paid a dividend of $0.65 per share. This represents a $2.60 annualized dividend and a yield of 3.5%. The ex-dividend date of this dividend was Monday, November 10th. Moelis & Company’s dividend payout ratio (DPR) is 86.96%.
Moelis & Company News Summary
Here are the key news stories impacting Moelis & Company this week:
- Positive Sentiment: Morgan Stanley raised its price target to $89 and maintained an “overweight” rating — a material bullish signal that implies meaningful upside vs. the current share level. Article Title
- Positive Sentiment: Zacks Research nudged up EPS forecasts across multiple periods (Q4 2025, FY2025, Q2 2026, Q4 2026, FY2026, Q1 & Q2 2027 and FY2027), with FY2027 now seen at $4.38 from $4.35 — these upgrades point to improving analyst expectations for fee generation and profitability. Zacks’ rating remains “Hold,” however, so the revisions are supportive but cautious.
- Neutral Sentiment: UBS raised its price target modestly from $70 to $74 but kept a “neutral” rating, signaling limited near‑term upside from that shop and a balanced view on risk/reward. Article Title
- Neutral Sentiment: Coverage roundups and analyst commentary (e.g., Benzinga’s “Beyond The Numbers” piece) are highlighting divergent views — some firms raising targets and estimates, others staying cautious — which can increase intraday volatility as investors parse who is right. Article Title
Moelis & Company Company Profile
Moelis & Co operates as a holding company. It engages in the provision of financial advisory, capital raising and asset management services to a client base including corporations, governments, sovereign wealth funds and financial sponsors. The firm focuses on clients including large public multinational corporations, middle market private companies, financial sponsors, entrepreneurs and governments. The company was founded by Kenneth David Moelis, Navid Mahmoodzadegan, Jeffrey Raich and Elizabeth Ann Crain in July 2007 and is headquartered in New York, NY.
Recommended Stories
- Five stocks we like better than Moelis & Company
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Do not delete, read immediately
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for Moelis & Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moelis & Company and related companies with MarketBeat.com's FREE daily email newsletter.
